LAVA Therapeutics NV Share Premium
LAVA Therapeutics NV had Share Premium of $41.09 million as of 2020-12-31, per its 20-F filed 2023-04-11.
Discontinued › Notes
ifrs-full:SharePremium · last filed 2023-04-11
- 2020-12-31: Share Premium $41.09M.
- 2020-01-01: Share Premium $19.56M.
- 2019-12-31: Share Premium $19.56M.
| Period end | Share Premium |
|---|---|
| 2020-12-31 | $41.09M 20-F · filed 2023-04-11 |
| 2020-01-01 | $19.56M 20-F/A · filed 2022-12-23 |
| 2019-12-31 | $19.56M 20-F/A · filed 2022-12-23 |